Chinese biotechs are increasingly seeking deals with multinational companies, and those deal structures are getting more creative. The “newco” deal structure is getting a lot of attention, but the ...

Faced with the encroaching threats of patent expirations and generics, biopharma companies in 2024 invested 33% more in ...

AstraZeneca investors will look past another strong set of quarterly results on Thursday to focus on the main issue ...

SINGAPORE (Reuters) - As China and the U.S. battle over tariffs, locked in a tussle that could result in a deal or a trade ...

Toyota is developing and making electric vehicles and EV batteries in China under a new partnership with the Shanghai ...

Asian shares are trading mostly lower as markets mull the impact of tariffs being imposed by the United States and China.

Beijing hit back with its own tariffs and export restrictions after being subjected to levies by President Trump. Trade ...

China opened an antitrust probe against Google as part of a sweeping set of retaliatory measures targeting the US economy ...

China has announced a flurry of retaliatory measures against the U.S., including tariffs on imports of products such as coal, ...

The shipment of Chinese sodium perchlorate indicates a rapid rebuilding of Iran’s missile industry since Israeli strikes in ...

A growing number of countries, including American allies, are striking trade deals as the Trump administration erects a ...